Jain et al. [38] combined information on TP53 mutation status in breast carcinomas with their genomic complexity, as assessed by chromosomal comparative genomic hybridization (CGH), a technique capable of detecting copy number alterations at chromosomal level [39]. This evidence concerns the gene TP53 and breast carcinoma.